INVIVYD ($IVVD) is expected to release its quarterly earnings data on Thursday, May 15th before market open, per Finnhub. Analysts are expecting revenue of $35,139,336 and earnings of -$0.03 per share.
You can see Quiver Quantitative's $IVVD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INVIVYD Insider Trading Activity
INVIVYD insiders have traded $IVVD stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $IVVD stock by insiders over the last 6 months:
- TERRANCE MCGUIRE has made 0 purchases and 15 sales selling 1,621,322 shares for an estimated $836,953.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
INVIVYD Hedge Fund Activity
We have seen 37 institutional investors add shares of INVIVYD stock to their portfolio, and 41 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SLATE PATH CAPITAL LP removed 3,735,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,654,978
- FMR LLC removed 3,714,554 shares (-64.3%) from their portfolio in Q1 2025, for an estimated $2,248,419
- BLACKROCK, INC. added 605,758 shares (+12.8%) to their portfolio in Q1 2025, for an estimated $366,665
- ORBIMED ADVISORS LLC removed 579,000 shares (-33.5%) from their portfolio in Q4 2024, for an estimated $256,554
- CITADEL ADVISORS LLC removed 559,456 shares (-89.5%) from their portfolio in Q4 2024, for an estimated $247,894
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 547,290 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $242,504
- MILLENNIUM MANAGEMENT LLC removed 326,721 shares (-89.6%) from their portfolio in Q4 2024, for an estimated $144,770
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
